Degraded elastin

Degraded elastin refers to the fragmented and chemically modified state of the extracellular matrix protein elastin, typically resulting from chronic inflammation and the overactivity of elastolytic enzymes like matrix metalloproteinases (MMPs). These degraded sites are central to the pathogenesis of abdominal aortic aneurysms (AAA) and vascular calcification, as the loss of elastin's structural integrity leads to vessel wall weakening and dilation (Basalyga et al., 2004). A defining characteristic of degraded elastin is the exposure of negatively charged carboxyl groups, which serve as high-affinity binding sites for divalent and trivalent metal ions. In a pathological context, the binding of divalent calcium ions (Ca2+) facilitates the formation of hydroxyapatite crystals, leading to arterial stiffening and further degradation (Vyavahare et al., 1999). Therapeutic interventions utilize trivalent metal ions, such as aluminum (Al3+) or iron (Fe3+), which bind to these sites with significantly higher affinity than calcium. This binding not only prevents calcification through competitive inhibition but also induces a conformational stabilization of the elastin fibers, making them resistant to further proteolytic attack (Isenburg et al., 2007). Consequently, degraded elastin serves as both a structural target for stabilization and a site for targeted drug delivery in cardiovascular and pulmonary medicine.

Other names

Elastin-degraded sitesFragmented elastinCalcified elastinElastin-derived peptidesEDPsTropoelastin fragments

Trivalent metal ions (such as Al3+ or Fe3+) bind with high affinity to exposed carboxyl groups on degraded elastin fibers, creating stable coordination complexes that displace divalent calcium ions and provide resistance against further proteolytic degradation by matrix metalloproteinases and elastases.